Stock analysis, price data, and AI-powered insights for Cardinal Health (CAH).
Cardinal Health operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for CAH.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). CAH Stock Intelligence Report. [stoxpulse.com/stocks/cah]
Disclaimer: The information on this page about Cardinal Health (CAH) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Cardinal Health.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings beat by 13%
Mar 31
Hall bought 381 shares
Apr 15
Greene sold 100 shares
Feb 27
Charles River Prepares to Report Q2 Earnings: What...
9h ago
CONMED Q2 Earnings and Revenues Beat Estimates, Gr...
10h ago
StoxPulse AI results for CAH: Pulse Score 57/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$53.18B
P/E Ratio
25.9
EPS
$1.97
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Jun 25
+1.1%
Sep 25
+15.9%
Dec 25
+9.4%
Mar 26
+12.6%
Beat estimates 4 of 4 quarters (100%)
Sector
Healthcare
Industry
Health Care Distributors
Charles River Prepares to Report Q2 Earnings: What's in Store?
CONMED Q2 Earnings and Revenues Beat Estimates, Gross Margin Expands
Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised
Here is Why Growth Investors Should Buy Cardinal (CAH) Now
Revvity to Report Q2 Earnings: What's in Store for the Stock?
BAX Stock Gains on Q2 Earnings & Sales Beat, Margins Contract
Glaukos Q2 Earnings Beat Estimates on iDose TR Growth, Stock Up
GEHC Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market